Outcome study following reimbursement changes in the use of fixed combination inhalers in patients with asthma or Chronic Obstructive Pulmonary Disease
Study identifier:NIS-RSE-DUM-2010/2
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Outcome study following reimbursement changes in the use of fixed combination inhalers in patients with asthma or COPD in Iceland
Medical condition
asthma
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
20000
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Jul 2011
Primary Completion Date: 01 Sept 2013
Study Completion Date: 01 Sept 2013
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Sept 2014 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 All patients who was on treatment with fixed combination asthma or COPD therapy by January 1 2010 | - |
Contacts
Investigators
Principal Investigator
Unnur Steina Björnsdottir
University of Iceland
